NewsBenzinga艾伯维表示，在2期APEX B部分特应性皮炎研究中，Zumilokibart三种给药方案均达到主要终点，且第16周EASI-75应答率显著高于安慰剂 艾伯维表示，在2期APEX B部分特应性皮炎研究中，Zumilokibart三种给药方案均达到主要终点，且第16周EASI-75应答率显著高于安慰剂 Benzinga 2026.09.30 06:54 (GMT+0) Open on Benzinga Other news What to Expect From Fifth Third Bancorp's Q3 2026 Earnings Report Petrovietnam Unit BSR Signs ExxonMobil Asia-Pacific Crude Supply Agreement Ensuring Minimum 2M Barrels Yearly For Dung Quat Refinery, Alongside Chevron Framework Pact DoorDash Expands India Footprint With Hyderabad Global Tech Hub, Adding To Pune Office, And Plans 3,000 Jobs Reported Earlier, DBV Technologies Submits BLA To FDA For VIASKIN Peanut Patch In Children Aged 4-7 With Peanut Allergy, Requests Priority Review BA Stock Climbs After Boeing Secures $20 Billion Contract as Pentagon Pushes Next-Generation Carrier Fighter Program After Years of Delays Victory Capital Holdings: Multiple Pillars Of Growth (NASDAQ:VCTR)
Petrovietnam Unit BSR Signs ExxonMobil Asia-Pacific Crude Supply Agreement Ensuring Minimum 2M Barrels Yearly For Dung Quat Refinery, Alongside Chevron Framework Pact
DoorDash Expands India Footprint With Hyderabad Global Tech Hub, Adding To Pune Office, And Plans 3,000 Jobs
Reported Earlier, DBV Technologies Submits BLA To FDA For VIASKIN Peanut Patch In Children Aged 4-7 With Peanut Allergy, Requests Priority Review
BA Stock Climbs After Boeing Secures $20 Billion Contract as Pentagon Pushes Next-Generation Carrier Fighter Program After Years of Delays
